Immunotherapy against cancer-related viruses

Hepatitis B and cancer: A practical guide for the oncologist

(2016) Claudia Bozza et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Combinatorial immunotherapy strategies for hepatocellular carcinoma

(2016) Maria Tagliamonte et al.   CURRENT OPINION IN IMMUNOLOGY

Prospects for gene-engineered T cell immunotherapy for solid cancers

(2016) Christopher A Klebanoff et al.   NATURE MEDICINE

Global burden of cancers attributable to infections in 2012: a synthetic analysis

(2016) Martyn Plummer et al.   Lancet Global Health

Preventing Cervical Cancer in the United States: Barriers and Resolutions for HPV Vaccination

(2016) Anna Louise Beavis et al.   Frontiers in Oncology

Effectiveness of sofosbuvir-based regimens in genotype 1 and 2 hepatitis C virus infection in 4026 U.S. Veterans

(2015) L. I. Backus et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6

(2015) L. M. Draper et al.   CLINICAL CANCER RESEARCH

Safety of human papillomavirus vaccines: a review

(2015) Michela Stillo et al.   Expert Opinion On Drug Safety

Immunotherapeutic Approaches for the Control and Eradication of HIV

(2015) Daniel Amsterdam   IMMUNOLOGICAL INVESTIGATIONS

Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells

(2015) Sanja Stevanović et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs

(2015) Seok-Goo Cho et al.   MOLECULAR THERAPY

Success and failure of the cellular immune response against HIV-1

(2015) Stephen A Migueles et al.   NATURE IMMUNOLOGY

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

(2015) Elmar A. Joura et al.   NEW ENGLAND JOURNAL OF MEDICINE

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

(2015) Stephen M. Ansell et al.   NEW ENGLAND JOURNAL OF MEDICINE

Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age

(2015) Ting-Xun Lu et al.   Scientific Reports

Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus

(2015) Natalie Kash et al.   Journal of Clinical Medicine

Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells

(2014) I. Ricciardelli et al.   BLOOD

The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: A comprehensive and evidence-based comparison and review

(2014) Zhi Ven Fong et al.   CANCER

Human Viral Oncogenesis: A Cancer Hallmarks Analysis

(2014) Enrique A. Mesri et al.   Cell Host & Microbe

A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein-Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer

(2014) G. S. Taylor et al.   CLINICAL CANCER RESEARCH

The role of sexual behavior in head and neck cancer: implications for prevention and therapy

(2014) Eleni Rettig et al.   Expert Review of Anticancer Therapy

Antiviral T-cell therapy

(2014) Ann M. Leen et al.   IMMUNOLOGICAL REVIEWS

Complementation of Antigen-presenting Cells to Generate T Lymphocytes With Broad Target Specificity

(2014) Minhtran Charlotte Ngo et al.   JOURNAL OF IMMUNOTHERAPY

The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets

(2014) Marc Ringelhan et al.   JOURNAL OF PATHOLOGY

The role of Epstein-Barr virus in epithelial malignancies

(2014) Sai-Wah Tsao et al.   JOURNAL OF PATHOLOGY

Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine Receptor

(2014) Ann M Leen et al.   MOLECULAR THERAPY

Epigenetic Manipulation Restores Functions of Defective CD8+ T Cells From Chronic Viral Infection

(2014) Fuqin Zhang et al.   MOLECULAR THERAPY

Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT

(2014) A. Papadopoulou et al.   Science Translational Medicine

Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients

(2014) Tae Jin Kim et al.   Nature Communications

A meta-analysis of cytokine-induced killer cells therapy in combination with minimally invasive treatment for hepatocellular carcinoma

(2014) Xiaofeng Li et al.   Clinics and Research in Hepatology and Gastroenterology

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

(2013) A. M. Leen et al.   BLOOD

Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins

(2013) Catherine M. Bollard et al.   JOURNAL OF CLINICAL ONCOLOGY

Challenges in cancer vaccine development for hepatocellular carcinoma

(2013) Luigi Buonaguro et al.   JOURNAL OF HEPATOLOGY

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

(2013) Ulrike Gerdemann et al.   MOLECULAR THERAPY

Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma

(2013) Whay-Kuang Chia et al.   MOLECULAR THERAPY

The pathogenesis of Epstein–Barr virus persistent infection

(2013) David A Thorley-Lawson et al.   Current Opinion in Virology

Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning

(2012) H. J. Pegram et al.   BLOOD

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma

(2012) Tim F Greten et al.   BMC CANCER

Cytokine-induced killer cells in the treatment of patients with solid carcinomas: a systematic review and pooled analysis

(2012) Yue Ma et al.   CYTOTHERAPY

Human Papillomavirus Type 16 E6/E7-specific Cytotoxic T Lymphocytes for Adoptive Immunotherapy of HPV-associated Malignancies

(2012) Carlos A. Ramos et al.   JOURNAL OF IMMUNOTHERAPY

T-cell therapy in the treatment of post-transplant lymphoproliferative disease

(2012) Catherine M. Bollard et al.   Nature Reviews Clinical Oncology

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

(2012) Julie R. Brahmer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Merkel cell polyomavirus: A newly discovered human virus with oncogenic potential

(2012) Megan E. Spurgeon et al.   VIROLOGY

Epstein-Barr Virus (EBV)-associated Gastric Carcinoma

(2012) Hisashi Iizasa et al.   Viruses-Basel

Immunotherapy of hepatocellular carcinoma

(2012) Angela D. Pardee et al.   OncoImmunology

T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results

(2011) S. Secondino et al.   ANNALS OF ONCOLOGY

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation

(2011) E. Doubrovina et al.   BLOOD

Immune defence against EBV and EBV-associated disease

(2011) Heather M Long et al.   CURRENT OPINION IN IMMUNOLOGY

The PD-1/PD-L1 (B7-H1) Pathway in Chronic Infection-Induced Cytotoxic T Lymphocyte Exhaustion

(2011) Kimberly A. Hofmeyer et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Combining mTor Inhibitors With Rapamycin-resistant T Cells: A Two-pronged Approach to Tumor Elimination

(2011) Leslie E Huye et al.   MOLECULAR THERAPY

Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer

(2011) D R McGivern et al.   ONCOGENE

Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention

(2011) J. I. Cohen et al.   Science Translational Medicine

Immunobiology of Merkel Cell Carcinoma: Implications for Immunotherapy of a Polyomavirus-Associated Cancer

(2011) Shailender Bhatia et al.   Current Oncology Reports

Vaccines to Prevent Infections by Oncoviruses

(2010) John T. Schiller et al.   Annual Review of Microbiology

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes

(2010) J. N. Barker et al.   BLOOD

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

(2010) A. Moosmann et al.   BLOOD

Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma

(2010) Chrystal U. Louis et al.   JOURNAL OF IMMUNOTHERAPY

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy

(2010) M Matsuoka et al.   ONCOGENE

Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)

(2009) B. De Angelis et al.   BLOOD

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

(2009) H. E. Heslop et al.   BLOOD

A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation

(2009) Michael Uhlin et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Role of the Epstein–Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma

(2009) Mhairi A Morris et al.   Future Oncology

Genetic Manipulation of Tumor-specific Cytotoxic T Lymphocytes to Restore Responsiveness to IL-7

(2009) Juan F Vera et al.   MOLECULAR THERAPY

Human tumor-associated viruses and new insights into the molecular mechanisms of cancer

(2009) D Martin et al.   ONCOGENE

Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma

(2009) M. H. Fogg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Phase I Trial of Epstein-Barr Virus Gp350 Vaccine for Children With Chronic Kidney Disease Awaiting Transplantation

(2009) Lesley Rees et al.   TRANSPLANTATION

Papillomaviruses in the causation of human cancers — a brief historical account

(2009) Harald zur Hausen   VIROLOGY

Mechanism of Genomic Instability in Cells Infected with the High-Risk Human Papillomaviruses

(2009) Meelis Kadaja et al.   PLoS Pathogens

The Dynamics of EBV Shedding Implicate a Central Role for Epithelial Cells in Amplifying Viral Output

(2009) Vey Hadinoto et al.   PLoS Pathogens

Immunotherapy targeting EBV-expressing lymphoproliferative diseases

(2008) Catherine M. Bollard et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

The History of Tumor Virology

(2008) R. T. Javier et al.   CANCER RESEARCH

Infections and cancer: Established associations and new hypotheses

(2008) Catherine de Martel et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

EBV-Associated Lymphoproliferative Disorders: Classification and Treatment

(2008) A. Carbone et al.   ONCOLOGIST

Epstein-Barr virus: a paradigm for persistent infection – for real and in virtual reality

(2008) David A. Thorley-Lawson et al.   TRENDS IN IMMUNOLOGY

Viruses associated with human cancer

(2007) Margaret E. McLaughlin-Drubin et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

T cell therapy of Epstein–Barr virus and adenovirus infections after hemopoietic stem cell transplant

(2007) P. Comoli et al.   BLOOD CELLS MOLECULES AND DISEASES